Research Article
SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence
Table 1
Clinicopathological features of 166 NSCLC patients.
| | Characteristics | Clinical stage | | Stage I () | Stage II () | Stage III () | Stage IV () |
| | Age (years) | | | | | | Median (range), y | 66 (34-85) | 68 (46-88) | 66.5 (35-79) | 65.5 (32-81) | | Sex | | | | | | Male | 24 | 24 | 35 | 32 | | Female | 16 | 12 | 9 | 14 | | Smoking history | | | | | | Never | 25 | 15 | 16 | 20 | | Former/current | 15 | 21 | 28 | 26 | | Histology | | | | | | Adenocarcinoma | 28 | 21 | 20 | 27 | | Squamous carcinoma | 12 | 14 | 24 | 16 | | Adenosquamous carcinoma | 0 | 0 | 0 | 2 | | Poorly differentiated NSCLC | 0 | 1 | 0 | 1 |
|
|
NSCLC: nonsmall cell lung cancer.
|
